Serum cholinesterase activity helps to distinguish between liver disease and non-liver disease aberration in liver function tests
Citations Over TimeTop 20% of 2006 papers
Abstract
The diagnostic usefulness of a single determination of serum cholinesterase activity to distinguish between overt liver disease and non-liver disease clinical problems in which a few of the traditional liver function tests are abnormal was assessed. Using three groups of subjects comprising liver disease, non-liver disease, and healthy controls, we have shown that serum cholinesterase activity helped to distinguish between liver disease and non-liver disease in subjects who had abnormality of a few liver function tests. Serum cholinesterase activity helped also to distinguish between the liver disease subjects and healthy controls. There was no statistically significant difference between the mean serum cholinesterase activities of non-liver disease subjects and healthy controls. We suggest that determination of serum cholinesterase activity is a cost-effective diagnostic means of differentiating between overt liver disease and non-liver diseases where there may be aberration of some liver function tests.
Related Papers
- → Serum cholinesterase activity helps to distinguish between liver disease and non-liver disease aberration in liver function tests(2006)96 cited
- → COVID-19 induced liver function abnormality associates with age(2020)19 cited
- → Serum cholinesterase as diagnostic marker of liver disease(2014)6 cited
- → Retrospective Observation of Liver Function Test in 147 Patients Admitted to Korean Medicine Hospital(2018)
- COVID-19 INDUCED LIVER FUNCTION ABNORMALITY(2020)